Funder
Division of Loan Repayment
Division of Cancer Epidemiology and Genetics, National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Testicular Cancer: Statistics, in Board CNE (ed): Testicular cancer guide, 2005–2022 American Society of Clinical Oncology (ASCO), 02/2022. https://www.cancer.net/cancer-types/testicular-cancer/statistics
2. Trama A, Foschi R, Larrañaga N, et al. Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: results from the EUROCARE-5 study. Eur J Cancer. 2015;51:2206–16.
3. Einhorn LH, Williams SD, Chamness A, et al. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med. 2007;357:340–8.
4. Fung C, Fossa SD, Milano MT, et al. Cardiovascular disease mortality after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol. 2015;33:3105–15.
5. •• Lauritsen J, Hansen MK, Bandak M, Kreiberg MB, Skøtt JW, Wagner T, Gundgaard Kier MG, Holm NV, Agerbæk M, Gupta R, Dehlendorff C, Andersen KK, Daugaard G. Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer. J Clin Oncol. 2020;38(6):584-592. https://doi.org/10.1200/JCO.19.01180. This well-designed thoughtful national cohort study has defined the prevalence of both cardiovascular risk factors and cardiovascular disease in testicular cancer survivorship.